LPA and obesity due to melanocortin 4 receptor deficiency: Additionally, the elevated Lp(a) levels in standard-weight MI patients, as opposed to their overweight and obese counterparts, suggest that Lp(a) may independently elevate cardiovascular risk, especially in the absence of other conventional risk factors like obesity.